Litigation Details for PACIRA PHARMACEUTICALS, INC. v. EVENUS PHARMACEUTICALS LABORATORIES INC. (D.N.J. 2021)

PACIRA PHARMACEUTICALS, INC. v. EVENUS PHARMACEUTICALS LABORATORIES INC. (D.N.J. 2021)

Docket		Date Filed	2021-11-08
Court	District Court, D. New Jersey	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Madeline Cox Arleo
Jury Demand	None	Referred To	Cathy L. Waldor
Patents	9,585,838
Link to Docket	External link to docket

Details for PACIRA PHARMACEUTICALS, INC. v. EVENUS PHARMACEUTICALS LABORATORIES INC. (D.N.J. 2021)

Date Filed	Document No.	Description	Snippet	Link To Document
2023-06-06	187	Opinion	No. 9,585,838 and is incorporated by reference in its entirety.” Id. at 4:31-35. That patent – the…; 9,205,052 (expired September 18, 2018); and 9,585,838 (expired December 24, 2021). See Def. Exs. 18…The patents at issue here, the 11,033,495 patent (the “‘495 Patent”) and the 11,179,336 patent (the…11,426,348 (“‘348 Patent”); 11,278,494 (“‘493 Patent”); and 11,357,727 (“‘727 Patent”). See Def Exs. 4-5. …Ex. 1 (“‘495 Patent”) at 1:32-26; Pl. Ex. 2 (“‘336 patent”) at 1:39- 43. Both patents inform that the	External link to document
2022-10-21	97	Statement	U.S. Patent No. 9,585,838 (“’838 patent”): bupivacaine encapsulated …evidence: U.S. Patent No. 9,585,838 (the “’838 patent”) generally…infringement of U.S. Patent Nos. 11,033,495 (the “’495 Patent”) and 11,179,336 (the “’336 Patent”) (collectively…History of the ʼ336 Patent: July 16, 2021 ’336 Patent, claims 1-20; ’336 Patent generally, including…Statement. II. CONSTRUCTION OF PATENT TERMS A. Local Patent Rule 4.3(a): Agreed Upon Claim	External link to document